Treatment of patients with hepatitis C virus on the waiting list
- PMID: 14586902
- DOI: 10.1053/jlts.2003.50247
Treatment of patients with hepatitis C virus on the waiting list
Abstract
1. Over 90% of patients with hepatitis C on the waiting list might be candidates for therapy with interferon plus ribavirin. 2. One must exercise caution in the treatment of these patients. Those with Child-Turcotte-Pugh score >11 or Model for End-Stage Liver Disease score >25 should be excluded from treatment. 3. Sustained virologic response (hepatitis C virus RNA-negative) is mainly dependent on viral genotype, with 50% of genotype 2 and 3 patients achieving sustained virologic response. 4. The ability to achieve sustained virologic response in genotype 1 patients is dependent on dose and duration of treatment. 5. Patients rendered hepatitis C virus RNA-negative pretransplantation may not experience posttransplantation recurrence.
Similar articles
-
Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.Eur J Gastroenterol Hepatol. 2008 Aug;20(8):778-83. doi: 10.1097/MEG.0b013e3282f762f8. Eur J Gastroenterol Hepatol. 2008. PMID: 18617783
-
Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.Transplant Proc. 2004 Jul-Aug;36(6):1831-4. doi: 10.1016/j.transproceed.2004.07.025. Transplant Proc. 2004. PMID: 15350490 Clinical Trial.
-
Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.Transplant Proc. 2006 May;38(4):1127-30. doi: 10.1016/j.transproceed.2006.02.135. Transplant Proc. 2006. PMID: 16757285
-
Hepatitis C therapy before and after liver transplantation.Liver Transpl. 2008 Oct;14 Suppl 2:S58-66. doi: 10.1002/lt.21624. Liver Transpl. 2008. PMID: 18825697 Review.
-
Management of recurrent hepatitis C after liver transplantation: a concise review.Am J Gastroenterol. 2000 Sep;95(9):2164-70. doi: 10.1111/j.1572-0241.2000.02296.x. Am J Gastroenterol. 2000. PMID: 11007212 Review.
Cited by
-
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.Med Microbiol Immunol. 2010 Feb;199(1):1-10. doi: 10.1007/s00430-009-0131-8. Epub 2009 Nov 10. Med Microbiol Immunol. 2010. PMID: 19902246 Review.
-
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.World J Gastroenterol. 2008 Nov 14;14(42):6467-72. doi: 10.3748/wjg.14.6467. World J Gastroenterol. 2008. PMID: 19030197 Free PMC article. Review.
-
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.Can J Gastroenterol. 2006 Nov;20(11):725-34. doi: 10.1155/2006/238218. Can J Gastroenterol. 2006. PMID: 17111055 Free PMC article. Review.
-
Antiviral treatment for hepatitis C virus infection after liver transplantation.Hepat Res Treat. 2010;2010:475746. doi: 10.1155/2010/475746. Epub 2010 Nov 1. Hepat Res Treat. 2010. PMID: 21151523 Free PMC article.
-
Antiviral therapy in HCV-infected decompensated cirrhotics.Saudi J Gastroenterol. 2010 Oct-Dec;16(4):310-4. doi: 10.4103/1319-3767.70632. Saudi J Gastroenterol. 2010. PMID: 20871208 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical